logo

SOPH

Sophia Genetics·NASDAQ
--
--(--)
--
--(--)

SOPH fundamentals

Sophia Genetics (SOPH) expects to report earnings on Mar 3, 2026, with estimated revenue of 20.49M (YoY +15.55%), and EPS at -0.2375 (YoY -3.26%).
Revenue estimate / YoY
20.49M
+15.55%
EPS estimate / YoY
-0.2375
-3.26%
Report date
Mar 3, 2026
EPS
Revenue

Revenue & Expenses

SOPH has released its 2025 Q3 earnings report, with revenue of 19.46M, reflecting a YoY change of 22.77%, and net profit of -20.02M, showing a YoY change of -8.59%. The Sankey diagram below clearly presents SOPH's revenue sources and cost distribution.

Key Indicators

Sophia Genetics (SOPH) key financial stats and ratios, covering profitability, financial health, and leverage.
Sophia Genetics (SOPH)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Sophia Genetics (SOPH)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Sophia Genetics (SOPH)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Sophia Genetics (SOPH) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Sophia Genetics (SOPH) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield